Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose-Reference-Cited by-同舟云学术

Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose

Published:2017-02 Issue:2 Volume:3 Page:e129
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:Transplantation Direct

Author:

Andrews Louise M.,de Winter Brenda C.M.,Tang Jiang-Tao,Shuker Nauras,Bouamar Rachida,van Schaik Ron H.N.,Koch Birgit C.P.,van Gelder Teun,Hesselink Dennis A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant,2009

2. FK 506 for liver, kidney, and pancreas transplantation;Lancet,1989

3. Consensus document: therapeutic monitoring of tacrolimus (FK-506);Ther Drug Monit,1995

4. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Clin Pharmacokinet,2004

5. Optimization of initial tacrolimus dose using pharmacogenetic testing;Clin Pharmacol Ther,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling and Optimizing Dynamic Treatment Regimens in Continuous Time;ICSA Book Series in Statistics;2024

2. Incomplete Data and Potential Risks of Drugs in People with Obesity;Current Obesity Reports;2023-11-18

3. Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework;The Journal of Clinical Pharmacology;2023-11

4. Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients;Clinical Transplantation;2023-10-03

5. Tacrolimus Trough Level Variation and Its Correlation to Clinical Outcomes and Consequences in Solid Organ Transplantation;Transplant Research and Risk Management;2023-08